The Great Merck Buyback.. Dividend Too (MRK)

Health and Healthcare

Published: November 24, 2009 3:42 pm

Last Updated: March 30, 2020 2:14 pm

Merck & Co., Inc. (NYSE: MRK) barely has its Schering-Plough deal behind it. And today came the announcement of its dividend rate, but more importantly came word of a large share repurchase program. The quarterly dividend for common stock is remaining at $0.38 per quarter, which gives a yield of almost 4.20%. It also declared a quarterly dividend of $3.75 per share on the company’s mandatory convertible preferred stock for the first quarter of 2010. But this buyback is what will excite most investors.

Merck’s Board of Directors approved a share buyback plan for up to $3 billion of common stock for its treasury. These share purchases will be made on the open market or in block transactions or in privately negotiated transactions.

Unfortunately, a down trading day and a recent huge merger isn’t enough to please many. Trading floors and investors are also getting further and further away from caring about buying stocks ahead of Thanksgiving.

Merck shares late in the day are down 0.5% at $36.24 late in the day, and the 52-week trading range is $20.95 to $36.96.

JON C. OGG
NOVEMBER 24, 2009

Are You Ahead, or Behind on Retirement?

If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: am I ahead, or behind on my goals?

Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With Zoe Financial’s free matching tool, you can connect with trusted financial advisors in minutes.

Why wait? Click here to get started today!